Washington Dc, DCNCT05081245Now EnrollingIRB Ready

Autism Spectrum Disorder Clinical Trial in Washington Dc, DC

Access cutting-edge autism spectrum disorder treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.

Sponsored by MapLight Therapeutics

Quick Self-Assessment

See if you qualify for this Washington Dc location

Preparing your pre-screening questions...

Expert Care in Washington Dc

Access autism spectrum disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related autism spectrum disorder treatment provided free

Apply for This Washington Dc Location

Check if you qualify for this autism spectrum disorder clinical trial in Washington Dc, DC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Washington Dc

    Convenient for DC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Washington Dc site if eligible
  4. 4Begin participation

About This Autism Spectrum Disorder Study in Washington Dc

ML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and adult subjects with ASD. The primary objective is to evaluate the efficacy of ML-004 compared with placebo in the improvement of social communication deficits in subjects with ASD.

Sponsor: MapLight Therapeutics

Who Can Participate

Inclusion Criteria

Age 12 to 45 at screening
Has a designated care/study partner who can reliably report on symptoms
Has a diagnosis of Autism Spectrum Disorder (ASD)
Has a body mass index (BMI) 18 through 34 kg/m², inclusive
Full scale IQ (or equivalent) ≥55 score, with adequate verbal fluency, as determined by the Principal Investigator.
Psychoactive medications and adjunctive therapies are stable for 4 weeks prior to screening
Must be able to swallow study medication

Exclusion Criteria

Has Rett syndrome or Child Disintegrative Disorder
Has participated in any other study and received any other investigational medication (other than COVID-19 vaccination) or device within 60 days prior to screening
History of epilepsy without current adequate control, or any seizure in the 6 months preceding screening
History of suicidal ideation or behavior in the past 12 months, or a positive response to C-SSRS questions 4 and/or 5
Systolic blood pressure ≥140 mmHg (if a

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Washington Dc?

Yes, this clinical trial (NCT05081245) has an active research site in Washington Dc, DC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Autism Spectrum Disorder Treatment Options in Washington Dc, DC

If you're searching for autism spectrum disorder treatment options in Washington Dc, DC, this clinical trial (NCT05081245) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced autism spectrum disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all autism spectrum disorder clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Washington Dc, DC

See all pulmonary embolism clinical trials recruiting in Washington Dc — not just this study.

Browse Pulmonary Embolism Trials in Washington Dc

Ready to Join in Washington Dc?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Washington Dc, DC